This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas A. Peterman, MD, MSc; Harold W. Jaffe, MD; Paul M. Feorino, PhD; Jane P. Getchell, DrPH; Donna T. Warfield; Harry W. Haverkos, MD; Rand L. Stoneburner, MD, MPH; James W. Curran, MD, MPH

JAMA. 1985;254(20):2913-2917.

Abstract
By Aug 15, 1985, one hundred ninety-four cases of possible transfusion-associated acquired immunodeficiency syndrome (AIDS) had been reported to the Centers for Disease Control. Cases received their transfusions in 30 states. Infants account for 10% of the cases, suggesting an increased susceptibility to developing AIDS. Investigations one to six years after the transfusions have identified high-risk donors to 47 cases. Of 47 high-risk donors tested, 40 had a reactive serology for human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) antibody, including five with no risk for AIDS by history. The HTLV-III/LAV was isolated from 23 of 26 seroreactive high-risk donors, most of whom remained asymptomatic. Blood components that transmitted HTLV-III/LAV included red cells, platelets, plasma, and whole blood. The time from transfusion to diagnosis of AIDS ranged from four to 84 months. The risk of developing AIDS after a blood transfusion has been low and will be lowered further by using both self-deferral and antibody screening.

(JAMA 1985;254:2913-2917)

Author Affiliations
From the Center for Infectious Diseases, Centers for Disease Control, Atlanta (Drs Peterman, Jaffe, Feorino, Getchell, Haverkos, and Curran and Ms Warfield); and the New York City Department of Health (Dr Stoneburner). Dr Haverkos is now with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Footnotes
Reprint requests to the Epidemiology Section, AIDS Branch, Center for Infectious Diseases, Centers for Disease Control, 1600 Clifton Rd NE, Atlanta, GA 30333 (Dr Peterman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Use of Fibrin Tissue Adhesive to Reduce Blood Loss and the Need for Blood Transfusion After Total Knee Arthroplasty. A Prospective, Randomized, Multicenter Study
LEVY et al.
JBJS 1999;81:1580-8.
ABSTRACT | FULL TEXT  

Autotransfusion After Coronary Artery Bypass Grafting Halves the Number of Patients Needing Blood Transfusion
Schmidt et al.
Ann. Thorac. Surg. 1996;61:1177-1181.
ABSTRACT | FULL TEXT  

The HIV Information Project for Transfusion Recipients a Decade After Transfusion
King et al.
Arch Pediatr Adolesc Med 1995;149:680-685.
ABSTRACT  

Risk Factors for Kaposi's Sarcoma in Patients With Advanced Human Immunodeficiency Virus Disease Treated With Zidovudine
Gallant et al.
Arch Intern Med 1994;154:566-572.
ABSTRACT  

Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) by Exposure to Blood: Defining the Risk
Klein and Friedland
ANN INTERN MED 1990;113:729-730.
ABSTRACT  

Infection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations
Donegan et al.
ANN INTERN MED 1990;113:733-739.
ABSTRACT  

Strategies for Screening Blood for Human Immunodeficiency Virus Antibody: Use of a Decision Support System
Schwartz et al.
JAMA 1990;264:1704-1710.
ABSTRACT  

Autologous Blood Donations Prior to Elective Cardiac Surgery: Safety and Effect on Subsequent Blood Use
Owings et al.
JAMA 1989;262:1963-1968.
ABSTRACT  

Massive Transfusion in the Intensive Care Unit
Higgins and Klein
J Intensive Care Med 1989;4:221-233.
ABSTRACT  

Analysis of the Use of HIV Antibody Testing in a Minnesota Hospital
Henry et al.
JAMA 1988;259:229-232.
ABSTRACT  

Acquired Immunodeficiency Syndrome and Directed Blood Donations: A Dilemma for American Medicine
Kruskall and Umlas
Arch Surg 1988;123:23-25.
ABSTRACT  

Human T-Cell Lymphotropic Virus Type I Infection in Neonates
Hara et al.
Arch Pediatr Adolesc Med 1987;141:764-765.
ABSTRACT  

The Prevention of Acquired Immunodeficiency Syndrome in the United States: An Objective Strategy for Medicine, Public Health, Business, and the Community
Francis and Chin
JAMA 1987;257:1357-1366.
ABSTRACT  

Transmission of Human Immunodeficiency Virus by Transplantation of a Renal Allograft, with Development of the Acquired Immunodeficiency Syndrome
KUMAR et al.
ANN INTERN MED 1987;106:244-245.
ABSTRACT  

Risk of Human Immunodeficiency Virus Infection from Blood Donors Who Later Developed the Acquired Immunodeficiency Syndrome
WARD et al.
ANN INTERN MED 1987;106:61-62.
ABSTRACT  

Infection with Human Immunodeficiency Virus in the Hospital: Epidemiology, Infection Control, and Biosafety Considerations
CONTE
ANN INTERN MED 1986;105:730-736.
ABSTRACT  

Leads from the MMWR
JAMA 1986;255:593-598.